Tumour necrosis factor and interleukin 1 signalling: do MAPKK kinases connect it all?

By Eder J.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 9, 1997-10 ,pp. : 319-322

Elsevier

Access to resources Recommend Favorite

REHMANNIA GLUTINOSA INHIBITS TUMOUR NECROSIS FACTOR- AND INTERLEUKIN-1 SECRETION FROM MOUSE ASTROCYTES

By Kim H-M.   An C-S.   Jung K-Y.   Choo Y-K.   Park J-K.   Nam S-Y.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 171-176

Academic Press

Access to resources Recommend Favorite

The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis

By Inanir A   Özoran K   Tutkak H   Mermerci B  

The Journal of International Medical Research, Vol. 32, Iss. 6, 2004-11 ,pp. : 570-582

Field House Publishing

Access to resources Recommend Favorite

Interleukin-1 , interleukin-6, tumour necrosis factor- and interferon- released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes

By Bleau A.-M.   Maurel P.   Pichette V.   Leblond F.   du Souich P.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 197-206

Elsevier

Access to resources Recommend Favorite

Tumor necrosis factor- prevents interleukin-1 from augmenting capsaicin-induced vasodilatation in the rat skin

By Herbert M.K.   Hering S.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 273-279

Elsevier

Access to resources Recommend Favorite